CLINICAL_TRIALS
trial_result
· 2012-04-16
Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 study evaluating golimumab in active psoriatic arthritis shows safety and efficacy results; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Arthritis, Psoriatic | Phase 3 | Status: COMPLETED | Results posted: 2012-04-16